ASCENTAGE PHARMA GR-ADR (AAPG) Stock Cash Flow
NASDAQ:AAPG - Nasdaq - ADR - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | N/A | -932.86M | -887.17M | -832.25M | -675.45M | |||
| Depreciation Amortization | N/A | 77.31M | 61.47M | 28.33M | 27.42M | |||
| Change In Working Capital | -712.00M | -9.15M | 104.41M | 185.81M | -47.73M | |||
| Interest Paid | 71.13M | 92.35M | 49.85M | 16.81M | 5.93M | |||
| Taxes Paid | N/A | N/A | 0.00 | 3.85M | N/A | |||
| Other non cash items | N/A | 138.62M | 67.37M | 13.44M | 85.80M | |||
| OPERATING CASH FLOW | -712.00M | -726.08M | -653.91M | -604.68M | -609.96M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -38.59M | -56.84M | -236.96M | -436.63M | -251.48M | |||
| Other Investing Activity | -5.99M | 78.77M | -147.65M | -29.89M | 144.11M | |||
| INVESTING CASH FLOW | -44.58M | 21.92M | -384.61M | -466.52M | -107.37M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 8.16M | -13.36M | 695.87M | 539.50M | 425.13M | |||
| Stock Issued/Repurchased | 519.68M | 464.17M | -26.76M | 1.27B | 634.22M | |||
| Other Financing Activity | -217.81M | -82.06M | -49.85M | -32.88M | -19.35M | |||
| FINANCING CASH FLOW | 310.02M | 368.75M | 619.27M | 1.78B | 1.04B | |||
| Exchange Rate Effect | 9.01M | 27.81M | 58.01M | -23.28M | -41.69M | |||
| CHANGE IN CASH | -437.56M | -307.59M | -361.25M | 686.91M | 280.99M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -712.00M | -726.08M | -653.91M | -604.68M | -609.96M | |||
| Capital Expenditure | -38.59M | -56.84M | -236.96M | -436.63M | -251.48M | |||
| FREE CASH FLOW | -750.59M | -782.92M | -890.88M | -1.04B | -861.43M | |||
All data in CNY